The CDIATM Ecstasy Colloidal Gold Test Cassette (Urine) is a lateral flow chromatographic immunoassay for the detection of ecstasy and its metabolites in human urine.
Ecstasy antigen is coated on the test region of the nitrocellulose membrane of the strips, and ecstasy antibody is labeled with colloid gold. During a test, the colloid gold labeled antibody coated in the strip move forward along the membrane, and a red line will show up when the antibody gathers with the antigen in the test line; if ecstasy in the sample is over the detection limit, line T is blank; on the other wise, if ecstasy in the sample is less than the detection limit, line T is red.
MDMA belongs to a family of man-made drugs. Its relatives include MDA (methylenedioxyamphetamine), and MDEA (methylenedioxyethylamphetamine). They all share the amphetamine-like effects. MDMA is a stimulant with hallucinogenic tendencies described as an empathogen as it releases mood altering chemicals, such as cartooning and L-dopa, and may generate feelings of love and friendliness. The adverse effects of MDMA use include elevated blood pressure, hyperthermia, anxiety, paranoia and insomnia. MDMA is administered either by oral ingestion or intravenous injection. The effects of MDMA begin 30 minutes after intake, peak in an hour and last for 2–3 hours. The CDIATM Ecstasy Colloidal Gold Test Cassette (Urine) is a rapid urine-screening test that can be performed without the use of an instrument. The test utilizes a monoclonal antibody to selectively detect elevated levels of ecstasy in urine. The CDIATM ecstasy Colloidal Gold Test Cassette (Urine) yields a positive result when the ecstasy in urine exceeds 2000/1000/500 ng/mL.